Want to see HK:8161 full AI Analyst Report?
8161 Stock Chart & Stats
HK$0.60
-HK$0.01(-2.00%)
At close: 4:00 PM EST
HK$0.60
-HK$0.01(-2.00%)
Day’s Range― - ―
52-Week RangeHK$0.30 - HK$0.99
Previous CloseN/A
Volume192.00K
Average Volume (3M)13.20K
Market Cap
HK$19.97M
Enterprise ValueHK$23.35
Total Cash (Recent Filing)HK$10.17M
Total Debt (Recent Filing)HK$11.52M
Price to Earnings (P/E)―
Beta-0.02
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding41,600,000
10 Day Avg. Volume1,600
30 Day Avg. Volume13,200
Financial Highlights & Ratios
PEG Ratio0.05
Price to Book (P/B)2.68
Price to Sales (P/S)0.27
P/FCF Ratio20.57
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Positive Cash FlowPositive operating and free cash flow despite reported losses indicates the business still converts operations into cash, providing some funding capacity and reducing immediate dependence on external financing.
Improved Balance SheetThe substantial reduction in leverage from the 2024 stress point and rebuilding of equity improve financial resilience, even though debt remains meaningful for a smaller healthcare operator.
Prior Profitability CapabilityThe prior year’s positive operating profit and net margin demonstrate that the company has previously operated profitably, offering evidence of potential earnings recovery if revenue and margins can be stabilized.
Bears Say
Revenue ContractionA sharp revenue decline weakens operating leverage and reduces the scale available to support fixed costs, making a sustained recovery dependent on rebuilding demand and maintaining customer volumes.
Severe Margin And Earnings DeteriorationThe collapse in gross margin and return to losses indicate unstable pricing, costs, or service mix. Persistent margin volatility makes future earnings less predictable and raises execution risk.
Weakening Financial CushionAlthough cash flow remained positive, its steep deterioration alongside meaningful leverage leaves less room to absorb further operating weakness, fund investment, or meet obligations without additional financing.
8161 FAQ
What was MediNet Group Ltd.’s price range in the past 12 months?
MediNet Group Ltd. lowest stock price was HK$0.29 and its highest was HK$0.99 in the past 12 months.
What is MediNet Group Ltd.’s market cap?
MediNet Group Ltd.’s market cap is HK$19.97M.
When is MediNet Group Ltd.’s upcoming earnings report date?
MediNet Group Ltd.’s upcoming earnings report date is Nov 12, 2026 which is in 51 days.
How were MediNet Group Ltd.’s earnings last quarter?
MediNet Group Ltd. released its earnings results on Jun 29, 2026. The company reported -HK$0.077 earnings per share for the quarter.
Is MediNet Group Ltd. overvalued?
According to Wall Street analysts MediNet Group Ltd.’s price is currently Overvalued.
Does MediNet Group Ltd. pay dividends?
MediNet Group Ltd. does not currently pay dividends.
What is MediNet Group Ltd.’s EPS estimate?
MediNet Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MediNet Group Ltd. have?
MediNet Group Ltd. has 41,600,000 shares outstanding.
What happened to MediNet Group Ltd.’s price movement after its last earnings report?
MediNet Group Ltd. reported an EPS of -HK$0.077 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MediNet Group Ltd.?
Currently, no hedge funds are holding shares in HK:8161
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MediNet Group Ltd.
MediNet Group Limited, an investment holding entity, delivers a wide array of medical and dental services to corporations, insurance companies, and private individuals across Hong Kong and the People's Republic of China. The company manages two MediNet Centres, providing general practitioner consultations, immunization programs, men's health services, and comprehensive health assessments and body check-ups. Its operations also encompass six dental clinics, which offer a full spectrum of oral care, from routine services like scaling, polishing, fillings, and intra-oral X-rays, to advanced treatments such as cosmetic dentistry, orthodontics (including Invisalign), restorative solutions (dentures, veneers, implants), and oral and dental laser implant surgery, catering to both plan members and self-paying clients. Furthermore, MediNet operates a dedicated DNA genetic laboratory. The group also extends its services to include physiotherapy, traditional Chinese medicine practitioners, vaccinations, X-ray and diagnostic laboratory tests, and various specialist medical consultations. Additionally, MediNet utilizes online platforms to facilitate the sale of dental and medical consultation services. Established in 1994, the company is headquartered in Causeway Bay, Hong Kong, and operates as a subsidiary of MediNet International Limited.
Technical Analysis
Raily Aesthetic Medicine International Holdings Limited
―
Beauty Farm Medical & Health Industry, Inc.
―
Town Health International Medical Group Ltd.
―
Arrail Group Ltd.
―
Medicskin Holdings Ltd.
―